Mark Breidenbach
Stock Analyst at Oppenheimer
(3.7)
Main Sectors:
Top Industries:
24 Stocks
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
ALLO Allogene Therapeutic... | Maintains: Outperform | 9 7 | 1.33 | 426.32% | 6 | Aug 1, 2025 | |
NRIX Nurix Therapeutics | Maintains: Outperform | 27 30 | 9.38 | 219.83% | 4 | Sep 4, 2024 | |
EPIX ESSA Pharma | Reiterates: Outperform | 17 | n/a | n/a | 5 | Dec 13, 2023 | |
ALPN Alpine Immune Scienc... | Maintains: Outperform | 14 22 | n/a | n/a | 4 | Sep 11, 2023 | |
ARVN Arvinas | Reiterates: Outperform | 95 95 | 9.61 | 888.55% | 6 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 25 | 6.05 | 313.22% | 3 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Outperform | 10 | 0.73 | 1269.86% | 6 | Jun 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Outperform | 240 | 20.59 | 1065.61% | 4 | Jun 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 160 | 4 | 3900% | 1 | May 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 8 6 | n/a | n/a | 4 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 8 7 | 1.63 | 329.45% | 8 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 36 32 | 2.27 | 1309.69% | 2 | Mar 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 15 13 | n/a | n/a | 3 | Mar 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 25 15 | 2.34 | 541.03% | 7 | Mar 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 90 120 | 1.66 | 7128.92% | 4 | Oct 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Perform | n/a | n/a | n/a | 1 | Sep 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 92 86 | n/a | n/a | 4 | Feb 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 8 9 | n/a | n/a | 2 | Jul 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 23 | n/a | n/a | 1 | Apr 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 11250 9750 | 1.58 | 616988.61% | 2 | May 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | 2700 | n/a | n/a | 3 | Dec 13, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 75 65 | n/a | n/a | 4 | Dec 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 7 6 | n/a | n/a | 2 | Nov 15, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 2 | n/a | n/a | 1 | Apr 20, 2017 |